Surgical Workflow Determines BCI Winners

This tradeoff is really about turning a brain implant from a neurosurgery problem into a stent procedure. Synchron places its Stentrode through the jugular vein with standard catheter lab tools, then links it to a chest implant that sends signals wirelessly to phones and tablets. That makes the procedure easier for hospitals to add and easier for patients to accept, even if it captures less data than Neuralink’s threads, which require skull opening and robotic insertion into brain tissue.

• Synchron’s product is built around existing interventional radiology workflows. The implant procedure takes about two hours, uses equipment already common in cath labs, and patients are typically discharged in 1 to 2 days. That is a very different deployment model from building around specialized brain surgery teams.
  1 sacra 3 synchron
• The cost of less invasive access is lower bandwidth. Synchron uses a 16 electrode array in a blood vessel near the motor cortex, while Neuralink is pursuing a high channel intracortical system with more than 1,000 electrodes and long term plans for much higher counts. In practice, Synchron is optimizing for easier adoption first, Neuralink for richer control first.
  1 sacra 2 sacra 4 neuralink
• This is why the market is splitting into distinct product shapes, not just better or worse technology. Precision Neuroscience is also pushing a middle ground with cortical surface films inserted through small skull openings, which shows that surgical burden itself is becoming a core axis of competition alongside signal quality.
  1 sacra 2 sacra 5 nature

Going forward, the winners in BCI will likely be defined by which clinical workflow they fit. If Synchron can keep improving decoding and prove functional gains in larger trials, its less invasive path gives it a clearer route into more hospitals and more patients, while Neuralink remains better positioned for the highest performance use cases.